You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 206 No. 1, September 30, 1968 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Oral Contraceptives and Thromboembolic Disease

Victor A. Drill, MD, PhD; David W. Calhoun

JAMA. 1968;206(1):77-84.


Abstract

The average normal incidence of thrombophlebitis in nonpregnant women of childbearing age is one case per 1,000 women per year based on data from hospital admissions, and 2.2 cases per 1,000 women per year based on data from visits to the physician. The antepartum incidence is 0.5 cases per 1,000 women per nine months. In studies with oral contraceptives, the average incidence was 0.5 cases per 1,000 women per year. Evidence does not indicate that the administration of oral contraceptives to women with a history of thrombophlebitis increases the chance of recurrence of the disease. Data in the United States do not demonstrate an increase in death rate from pulmonary embolism, and vital statistics for England do not show an increase in the ratio of women to men dying from thromboembolic diseases since the introduction of oral contraceptives.



Author Affiliations

From the Division of Biological Research. G. D. Searle & Co., and the University of Illinois School of Medicine, Chicago (Dr. Drill).


Footnotes

Read in part before the 15th annual meeting of the Pacific Coast Fertility Society. Scottsdale, Ariz, Sept 28-Oct 30, 1967.

Reprint requests to 4900 Searle Pkwy, Skokie. Ill 60076 (Dr. Drill).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Deep-Vein Thrombosis
Weinmann and Salzman
NEJM 1994;331:1630-1641.
FULL TEXT  

Effect of an Oral Contraceptive Drug On Non-Arteriosclerotic, Male and Female Virgin Rats Vs. Arteriosclerotic, Male and Female Breeder Rats
Wexler
ANGIOLOGY 1974;25:197-227.
 

Spontaneous Rupture of the Liver in Patient Using Contraceptive Pills
Frederick et al.
Arch Surg 1974;108:93-95.
ABSTRACT  

Contraceptive Conundrum I
Catalano
Arch Dermatol 1972;106:571-572.
 

Oral Contraceptives and Thromboembolic Disease: I. Prospective and Retrospective Studies
Drill
JAMA 1972;219:583-592.
ABSTRACT  

Angiographically Verified Cerebrovascular Disease in Young Women On Oral Contraceptives Without Previous Neurological Illness"
Jacobs et al.
ANGIOLOGY 1971;22:511-520.
 

Medical Aspects of Oral Contraceptives
ELGEE
ANN INTERN MED 1970;72:409-418.
ABSTRACT  

Deep Vein Thrombophlebitis: Current Status of Etiology and Treatment
Laufman
Arch Surg 1969;99:489-493.
ABSTRACT  

Oral Contraceptives and Thromboembolism
Moses
JAMA 1969;208:694-694.
ABSTRACT  

Concerning the British Data
Doll et al.
JAMA 1969;207:1150-1151.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1968 American Medical Association. All Rights Reserved.